Scynexis (SCYX) Gross Profit (2013 - 2024)
Scynexis' (SCYX) quarterly Gross Profit came in at $977000.0 in Q4 2024, up 110.99% on a YoY basis from $463047.3 in Q1 2024, and up 48.03% quarter-over-quarter from $660000.0 in Q3 2024.
Analysis
Scynexis (SCYX) Gross Profit (2013 - 2024) Analysis & Trends
Scynexis (SCYX) has reported Gross Profit for 7 consecutive years, with $977000.0 the latest figure, recorded in Q4 2024.
- For the quarter ending Q4 2024, Gross Profit rose 110.99% year-over-year to $977000.0; the trailing twelve-month figure through Dec 2024 stood at $3.7 million (down 96.99% YoY), and the FY2024 full-year result was $3.7 million, down 96.99% from the prior year.
- Gross Profit improved to $977000.0 in Q4 2024 per SCYX's latest filing, from $660000.0 in the prior quarter.
- Across five years, Gross Profit topped out at $131.0 million in Q2 2023 and bottomed at -$8.9 million in Q4 2023.
- Historically, Gross Profit has averaged $9.7 million across 4 years, with a median of $993000.0 in 2023.
- The widest YoY moves for Gross Profit: up 11013.49% in 2023, down 769.2% in 2023.
- Over 4 years, Gross Profit stood at $430000.0 in 2021, then soared by 208.84% to $1.3 million in 2022, then slumped by 769.2% to -$8.9 million in 2023, then surged by 110.99% to $977000.0 in 2024.
- According to Business Quant data, Gross Profit over the past three periods registered $977000.0, $660000.0, and $736000.0 for Q4 2024, Q3 2024, and Q2 2024 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn |
| 10 | Scynexis | 58.41 Mn | -56.29 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 977,000.00 |
| Sep 30, 2024 | 660,000.00 |
| Jun 30, 2024 | 736,000.00 |
| Mar 31, 2024 | 1.37 Mn |
| Dec 31, 2023 | -8.89 Mn |
| Sep 30, 2023 | 1.38 Mn |
| Jun 30, 2023 | 131.03 Mn |
| Mar 31, 2023 | 993,000.00 |
| Dec 31, 2022 | 1.33 Mn |
| Sep 30, 2022 | 1.37 Mn |
| Jun 30, 2022 | 1.18 Mn |
| Mar 31, 2022 | 601,000.00 |
| Dec 31, 2021 | 430,000.00 |
| Sep 30, 2021 | 371,000.00 |
| Mar 31, 2021 | 12.05 Mn |
| Mar 31, 2015 | 66,000.00 |
| Dec 31, 2014 | 1.65 Mn |
| Sep 30, 2014 | 720,000.00 |
| Jun 30, 2014 | 462,000.00 |
| Mar 31, 2014 | 745,000.00 |